CRST Trademark
Trademark Overview
On Thursday, September 28, 2023, a trademark application was filed for CRST with the United States Patent and Trademark Office. The USPTO has given the CRST trademark a serial number of 98201920. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, December 9, 2024. This trademark is owned by ReNAgade Therapeutics Management, Inc.. The CRST trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Enzymes, nucleic acid molecules, and compounds and agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation
Chemical and biological agents for scientific and research use, namely, for the modification of small RNAs with targeting agents and for regulating expression and levels of mRNA with the modified RNAs; enzymes for scientific and research purposes; enzyme preparations for use in modifying small RNAs and for use of modified small RNAs in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes
Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry
General Information
| Serial Number | 98201920 |
| Word Mark | CRST |
| Filing Date | Thursday, September 28, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, December 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 31, 2024 |
Trademark Statements
| Goods and Services | Enzymes, nucleic acid molecules, and compounds and agents for modifying small RNAs with targeting agents for medical use, namely, use of the modified small RNAs in the gene editing industry; pharmaceutical preparations and therapeutic agents, namely, for gene therapy and mRNA regulation; pharmaceutical and biological preparations for medical use for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation |
| Goods and Services | Chemical and biological agents for scientific and research use, namely, for the modification of small RNAs with targeting agents and for regulating expression and levels of mRNA with the modified RNAs; enzymes for scientific and research purposes; enzyme preparations for use in modifying small RNAs and for use of modified small RNAs in the gene editing industry; Nucleic acid sequences for other than medical and veterinary purposes |
| Goods and Services | Research and development in the field of technology and engineering RNAs with targeting agents for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of RNA with targeting agents, namely, developing molecular and cellular biology reagents, techniques, and assays for use in the gene editing industry |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 12, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ReNAgade Therapeutics Management, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Watertown, MA 02472 |
Trademark Events
| Event Date | Event Description |
| Monday, October 2, 2023 | NEW APPLICATION ENTERED |
| Thursday, October 12, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 26, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 30, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 30, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, April 30, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, July 15, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, October 4, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 4, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, October 4, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, July 15, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, October 4, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 4, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 1, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, October 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, December 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
